JiXing is a leading biotechnology company headquartered in Shanghai and committed to bringing innovative science and medicines to underserved Chinese patients with serious and life-threatening diseases. Backed by RTW Investments, JiXing was founded in 2019 and partners with global biotechnology companies to develop and commercialise novel, innovative therapeutics to treat unmet medical needs in cardiovascular and ophthalmic diseases. With a strong and further developing asset pipeline, industry-leading talent, and patient-centric focus, at this key inflection point in JiXing's growth journey, we were commissioned to implement a full brand refresh, website design, and brand activation programme. https://www.jixing.com/en/